Research Suggests Equal Access to Therapy Could Close Multiple Myeloma Survival Gaps

A new study presented at the American Society of Clinical Oncology Annual Meeting indicates that racial disparities in multiple myeloma survival outcomes may be mitigated by equitable access to modern treatments. The research found that Black patients with equal access to advanced therapies did not show worse survival rates than white patients. These findings suggest that structural healthcare access issues, rather than biological differences, are key drivers of existing disparities.